ThinkEquity Initiates Coverage On Vivani Medical With Buy Rating, Announces Price Target of $7
ThinkEquity Initiates Coverage On Vivani Medical With Buy Rating, Announces Price Target of $7
ThinkEquity以買入評級啓動對Vivani Medical的保險，宣佈目標股價爲7美元
ThinkEquity analyst Ashok Kumar initiates coverage on Vivani Medical (NASDAQ:VANI) with a Buy rating and announces Price Target of $7.
ThinkEquity分析師阿肖克·庫馬爾以買入評級啓動了對Vivani Medical（納斯達克股票代碼：VANI）的報道，並宣佈目標股價爲7美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。